taurolidine has been researched along with Inflammatory Response Syndrome, Systemic in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brands, R; Kats, S; Schönberger, JP; Seinen, W; van Oeveren, W | 1 |
Bauhofer, A; Celik, I; Kohlert, F; Lorenz, W; Reckzeh, B; Stinner, B | 1 |
Leitermann, M; Radford, S; Willatts, SM | 1 |
Speller, DC; Willatts, SM; Winter, RJ | 1 |
1 review(s) available for taurolidine and Inflammatory Response Syndrome, Systemic
Article | Year |
---|---|
Endotoxin release in cardiac surgery with cardiopulmonary bypass: pathophysiology and possible therapeutic strategies. An update.
Topics: Adrenal Cortex Hormones; Alkaline Phosphatase; Anti-Infective Agents; Antibodies; Cardiopulmonary Bypass; Cytokines; Disaccharides; Endotoxins; Hemoperfusion; Humans; Hypothermia, Induced; Ketanserin; Serotonin Antagonists; Sugar Phosphates; Systemic Inflammatory Response Syndrome; Taurine; Thiadiazines; Toll-Like Receptor 4 | 2011 |
2 trial(s) available for taurolidine and Inflammatory Response Syndrome, Systemic
Article | Year |
---|---|
Effect of the antiendotoxic agent, taurolidine, in the treatment of sepsis syndrome: a placebo-controlled, double-blind trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; APACHE; Double-Blind Method; Female; Humans; Male; Middle Aged; Prospective Studies; Systemic Inflammatory Response Syndrome; Taurine; Thiadiazines; Treatment Outcome | 1995 |
Incidence of gram-negative bacteraemia in sepsis syndrome. Implications for immunotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; Critical Care; Double-Blind Method; Endotoxins; Female; Gram-Negative Bacterial Infections; Humans; Immunotherapy; Incidence; Male; Middle Aged; Systemic Inflammatory Response Syndrome; Taurine; Thiadiazines | 1994 |
1 other study(ies) available for taurolidine and Inflammatory Response Syndrome, Systemic
Article | Year |
---|---|
Granulocyte colony-stimulating factor but not peritoneal lavage increases survival rate after experimental abdominal contamination and infection.
Topics: Abdomen; Animals; Granulocyte Colony-Stimulating Factor; Male; Peritoneal Lavage; Random Allocation; Rats; Rats, Wistar; Sodium Chloride; Surgical Wound Infection; Survival Analysis; Systemic Inflammatory Response Syndrome; Taurine; Thiadiazines; Tumor Necrosis Factor-alpha | 2002 |